Cachetin/TNF: a macrophage protein that induces cachexia and shock.
暂无分享,去创建一个
[1] A. Cerami,et al. Recombinant human cachectin/tumor necrosis factor but not interleukin-1 alpha downregulates lipoprotein lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes , 1988, Molecular and cellular biology.
[2] L. Orci,et al. Lectin-gold labeling of glycoconjugates in normal and Brattleboro rat papilla: effect of vasopressin. , 1988, The American journal of physiology.
[3] K. Tracey,et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation , 1988, The Journal of experimental medicine.
[4] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[5] J. Gabrilove,et al. The acute metabolic effects of tumor necrosis factor administration in humans. , 1987, Archives of surgery.
[6] D. Donner,et al. Modulation of endogenous hormone action by recombinant human tumor necrosis factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[7] T. Ulich,et al. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. , 1987, Journal of immunology.
[8] C. Maury,et al. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection , 1987, The Journal of experimental medicine.
[9] A. Oliff,et al. Tumors secreting human TNF/cachectin induce cachexia in mice , 1987, Cell.
[10] W. Risau,et al. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Feingold,et al. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. , 1987, The Journal of clinical investigation.
[12] A. Cerami,et al. Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[13] B. Beutler,et al. Cachectin: more than a tumor necrosis factor. , 1987, The New England journal of medicine.
[14] H. Colten,et al. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. , 1986, The Journal of clinical investigation.
[15] H. Friedman,et al. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. , 1986, Journal of immunology.
[16] B. Aggarwal,et al. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[18] J. D. Albert,et al. Materials and Methods Brief Definitive Report CACHECTIN/TUMOR NECROSIS FACTOR MEDIATES CHANGES OF SKELETAL MUSCLE PLASMA MEMBRANE POTENTIAL , 2022 .
[19] R. Philip,et al. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1 , 1986, Nature.
[20] H. Ochs,et al. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. , 1986, Journal of immunology.
[21] B. Beutler,et al. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.
[22] J. Vilček,et al. Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma. , 1986, The Journal of biological chemistry.
[23] D. J. Millward,et al. The effects of endotoxaemia on protein metabolism in skeletal muscle and liver of fed and fasted rats. , 1986, The Biochemical journal.
[24] J. Larrick,et al. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. , 1986, Biochemical and biophysical research communications.
[25] W. Hunter,et al. Structure of an adenine˙cytosine base pair in DNA and its implications for mismatch repair , 1986, Nature.
[26] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[27] B. Beutler,et al. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. , 1985, Journal of immunology.
[28] B. Aggarwal,et al. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. , 1985, Journal of immunology.
[29] B. Beutler,et al. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. , 1985, Science.
[30] B. Beutler,et al. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.
[31] B. Beutler,et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin , 1985, Nature.
[32] B. Beutler,et al. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.
[33] D. Wilmore,et al. Combined Hormonal Infusion Simulates the Metabolic Response to Injury , 1984, Annals of surgery.
[34] P. Hotez,et al. Lipoprotein lipase suppression in 3T3‐L1 cells by a haematoprotozoan‐induced mediator from peritoneal exudate cells , 1984, Parasite immunology.
[35] G. Shires,et al. Membrane defect and energy status of rabbit skeletal muscle cells in sepsis and septic shock. , 1981, Archives of surgery.
[36] C. Cordova,et al. TYPE-III HYPERUPOPROTEINÆMIA , 1977, The Lancet.
[37] S. Morrison. Control of food intake in cancer cachexia: A challenge and a tool , 1976, Physiology & Behavior.
[38] W. Beisel,et al. Defective lipid disposal mechanisms during bacterial infection in rhesus monkeys. , 1976, Metabolism: clinical and experimental.
[39] W. Beisel,et al. Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms. , 1976, The Journal of infectious diseases.
[40] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[41] W. Thompson,et al. A protein from polymorphonuclear leukocytes (LEM) which affects the rate of hepatic amino acid transport and synthesis of acute-phase globulins. , 1975, Endocrinology.
[42] A. Theologides. THE ANOREXIA‐CACHEXIA SYNDROME: A NEW HYPOTHESIS , 1974 .
[43] J. A. Spitzer. Endotoxin-Induced Alterations in Isolated Fat Cells: Effect on Norepinephrine-Stimulated Lipolysis and Cyclic 3′,5′-Adenosine Monophosphate Accumulation , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[44] J. Gallin,et al. Serum lipids in infection. , 1969, The New England journal of medicine.
[45] R. Albertini,et al. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. , 1968, Lancet.
[46] R. Hirsch,et al. HYPERLIPIDEMIA, FATTY LIVER, AND BROMSULFOPHTHALEIN RETENTION IN RABBITS INJECTED INTRAVENOUSLY WITH BACTERIAL ENDOTOXINS. , 1964, Journal of lipid research.
[47] L. Moldawer,et al. Cachectin: its impact on metabolism and nutritional status. , 1988, Annual review of nutrition.
[48] G. Wong,et al. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons , 1986, Nature.
[49] S. Mittnacht,et al. Antiviral effects of recombinant tumour necrosis factor in vitro , 1986, Nature.
[50] J. Kinney,et al. Protein metabolism and injury. , 1983, Annual review of nutrition.
[51] C. Rouzer,et al. Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: role of defective triglyceride removal. , 1980, Molecular and biochemical parasitology.
[52] W. Beisel,et al. Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. , 1972, The Journal of infectious diseases.